Characterizing HBV Viral Particles Propagated by 5 Different Host Methods
Overview
Chronic infection with the Hepatitis B virus (HBV) often results in the development of cirrhosis and liver cancer, serving as one of the leading indications for liver transplantation. To date, there exists no therapeutic intervention that eliminates the viral genome from infected hepatocytes. Therefore, furthering our understanding of the molecular virology of HBV is critical for the development of novel antiviral strategies that mitigate the disease burden and control clinical outcomes in patients. For other viruses, experiments using mutants with gene deletions have been used to compare particle density, but no such studies exist for HBV. Thus, this study aims to better understand replication efficiency, characteristics, and infectivity of HBV virions by comparing particles secreted by 5 different host methods with standard complete and incomplete particle densities. My project evaluates particle physiology from humanized liver chimeric mice (PXB mice), transgenic mice, and the Hepatoma G2 cell line through density gradient ultracentrifugation, cell fractionation, quantification of DNA levels, and analysis of immunostained cells. The results indicated that viral particles propagated with in vivo infection of PXB mice had the highest infectivity around 1.6 × 107 copies/mL, while particles propagated in vitro with the HepG2 cell line exhibited the lowest, around 5.6 × 10³ copies/mL. Infectious particles fractionated between 1.25-1.37 g/cm³ and displayed differential degrees of infectivity based on the propagation method. These findings support my hypothesis that PXB mice are strong candidates for modeling viral infection, and that the propagation method affects particle characteristics.
Competition history
- ISEF 2022
Resources
Related projects
JSHS · 2023
Hepatitis B Patient-Derived Virus Exhibits Replication Step-Dependent Resistance to Interferon in a Chronic in-vitro Infection Model
ISEF · 2014
Constructing an HBV Reporter Virus
ISEF · 2021
Obtaining Highly Purified 3a NS5A Protein of Hepatitis C Virus
ISEF · 2026
qPCR Methodology for Quantifying Latent Hepatitis B Virus: First Step to Finding a Cure
JSHS · 2024
The Production of an Anti-PCHD1 Monoclonal Antibody for the Purpose of Combating Hantavirus
ISEF · 2014
Production of a Viral Enhancer Protein Using a Bacterial Platform
ISEF · 2014
Analysis of the ATP Hydrolysis Rate of Hepatitis C Viral Helicase in the Presence of PNR-379
ISEF · 2017
Statistical Analysis of Graft vs. Host Disease and Immune Reconstitution in Humanized Mice
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair